Advertisement

Topics

Latest "Functional Status, Morbidity and Mortality in Cemented Versus Press-Fit Hemiarthroplasty" News Stories

10:45 EDT 21st March 2019 | BioPortfolio

Here are the most relevant search results for "Functional Status, Morbidity and Mortality in Cemented Versus Press-Fit Hemiarthroplasty" found in our extensive news archives from over 250 global news sources.

More Information about Functional Status, Morbidity and Mortality in Cemented Versus Press-Fit Hemiarthroplasty on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Functional Status, Morbidity and Mortality in Cemented Versus Press-Fit Hemiarthroplasty for you to read. Along with our medical data and news we also list Functional Status, Morbidity and Mortality in Cemented Versus Press-Fit Hemiarthroplasty Clinical Trials, which are updated daily. BioPortfolio also has a large database of Functional Status, Morbidity and Mortality in Cemented Versus Press-Fit Hemiarthroplasty Companies for you to search.

Showing "Functional Status Morbidity Mortality Cemented Versus Press Hemiarthroplasty" News Articles 1–25 of 14,000+

Thursday 21st March 2019

Premier Inc. Analysis: Hospital-Associated Sepsis Decreased by 15% from 2015-2018

Sepsis-related mortalities, readmissions and incidences decline as hospital efforts to save lives yield success, but hospital-associated cases are 10 percent more likely to progress to septic shock, leading to a 20 percent increase in the cost per case Healthcare providers are becoming more adept at preventing and treating the top cause of hospital dea...


Customers’ experience leads to a highly successful outcome for Vetter at the 2019 CMO Leadership Awards

A win in all six core categories affirms Vetter as a trusted solution provider Vetter performs very well in customer-critical aspects Results directly reflect the experience of pharma and biotech companies in working alongside a trusted contractor More than 120 service providers assessed to determine the aw...

EVOTEC AG TO REPORT FISCAL YEAR 2018 RESULTS ON 28 MARCH 2019

DGAP-News: Evotec AG / Key word(s): Miscellaneous 21.03.2019 / 14:26 The issuer is solely responsible for the content of this announcement. Hamburg, Germany, 21 March 2019: Evotec AG (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) will report its financial results for 2018 on Thursday, 28 March 2019. The Company is going to hold a conference call to discuss the results...


CORRECTING and REPLACING Investment in Midwest Healthcare Companies Remains Steady at $2.5 Billion in 2018, Validating Record Increase of 43% in 2017

Minneapolis, Chicago and Cleveland lead the pack in investment, while the number of Midwest companies receiving funding increases 20% In the third bullet (Top-performing States) the dollar amount for Ohio should read $561 million (instead of $562 million). Also please replace the photo with the accompanying corrected photo. This press release features m...

Ligand to Receive Milestone and Royalties as Result of FDA Approval of Sage Therapeutics’ ZULRESSO™ (brexanolone) Injection

ZULRESSO is the first and only treatment specifically indicated for postpartum depression Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced that it will receive a $3 million milestone payment as a result of the U.S. Food and Drug Administration’s (FDA) approval of Sage Therapeutics’ (NASDAQ: SAGE) ZULRESSOTM (brexanolone) injection for t...

Gamida Cell Nominates Two Healthcare Industry Veterans to Its Board of Directors

– Shawn Cline Tomasello and Stephen T. Wills bring extensive experience in building successful commercial-stage life sciences companies – Gamida Cell Ltd. (Nasdaq: GMDA), a leading cellular and immune therapeutics company, today announced the nominations of Shawn Cline Tomasello and Stephen T. Wills to its board of directors. These nominatio...

FDA warns of increased mortality rates from drug-coated devices

Concerning reports about potential mortality rates caused by paclitaxel-coated devices have been raised by the FDA.

ZipLine Medical Announces New Emergency Department Study Showing Significant Time and Cost Savings, and Superior Patient Satisfaction, with Laceration Closure Using Zip® Surgical Skin Closure

ZipLine Medical, Inc. today announced presentation of positive results from a randomized, prospective clinical study conducted at the Karolinska University Hospital in Stockholm, Sweden demonstrating both clinical and economic benefits of the Zip® Surgical Skin Closure device when used in an emergency medicine setting for lacerations. A poster...

Leafbuyer Technologies, Inc. Announces Greenlight Platform Users Reach Nearly 80,000

Leafbuyer Technologies, Inc. (OTCMKTS: LBUY) (“Leafbuyer” or “the Company”), a leading cannabis technology platform, announced today the number of Greenlight platform users has reached nearly 80,000. The statement follows a March 13, 2019, release announcing Leafbuyer’s rollout of the Greenlight technology in Colorado and Oklahoma. ...

Investment in Midwest Healthcare Companies Remains Steady at $2.5 Billion in 2018, Validating Record Increase of 43% in 2017

Minneapolis, Chicago and Cleveland lead the pack in investment, while the number of Midwest companies receiving funding increases 20% Investment in Midwest healthcare companies remained steady in 2018, with $2.5 billion in capital raised by 438 companies. That amount of investment validates the record increase of 43% seen in 2017, demonstrating the sus...

Whoa, early stop. The last thing biotech needed.... https://twitter.com/buysidebio/status/1108684861890543616 …

Whoa, early stop. The last thing biotech needed.... https://twitter.com/buysidebio/status/1108684861890543616 …

The Netherlands Cancer Institute (NKI) selects Labguru to further pioneering cancer research and treatment

NKI completes institute wide adoption of Labguru to increase efficiency and maximize productivity in the laboratory 21 March 2019, Cambridge, MA — BioData has announced The Netherlands Cancer Institute (NKI) has started an institute wide deployment of its flagship product Labguru. NKI have secured an institutional licence of Labguru’s Electronic Lab Notebook (ELN) for further colla...

Aerie Pharmaceuticals Initiates Netarsudil Ophthalmic Solution Phase 2 Clinical Trial in Japan Designed to Support Requirements for Future Regulatory Filing

Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) (Aerie), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye, today announced the commencement of patient dosing in its Phase 2 clinical tri...

Oragenics Announces Pricing of $12.5 Million Underwritten Public Offering

Oragenics, Inc. (NYSE American: OGEN), a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, today announced the pricing of its previously announced underwritten public offering of 16,666,668 shares of common stock, short-term warrants to purchase up to 8,333,334 shares of common stock, and ...

Adrenomed's Adrecizumab successfully passes interim analysis in early septic shock study AdrenOSS-II

DGAP-News: Adrenomed AG / Key word(s): Study/Statement 21.03.2019 / 09:15 The issuer is solely responsible for the content of this announcement. Adrenomed's Adrecizumab successfully passes interim analysis in early septic shock study AdrenOSS-II - AdrenOSS-II trial continues as planned after positive interim efficacy analysis triggered by the treatment of 50% of randomized patients -...

PRMA Center for Advanced Breast Reconstruction Joins BRAVE Coalition Foundation in Celebrating BRAVE Day, Educating and Advocating for Breast Cancer Reconstruction Rights

BRAVE (Breast Restoration AdVocacy Education) Day aims to educate individuals on their breast reconstruction options and rights after breast cancer. SAN ANTONIO (PRWEB) March 21, 2019 March 21st is BRAVE (Breast Restoration AdVocacy Education) Day. This day serves as a reminder to educate women and men on their right to reconstruction after breast cancer treatment. According to the American Soc...

Innovent Announces First Patient Dosed in a Phase IIa Clinical Study of IBI306, an Anti-PCSK9 Monoclonal Antibody

SUZHOU, China, March 21, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines, today announced that the first patient has been successfully dosed in a Phase IIa clinical study of IBI306, a recombinant fully human anti-proprotein convertase substilisin/kexin type 9 (anti-PCSK...

IRW-News: Weekend Unlimited Inc.: Weekend Unlimited eröffnet Concept Store in Kalifornien

IRW-PRESS: Weekend Unlimited Inc.: Weekend Unlimited eröffnet Concept Store in Kalifornien Weekend Unlimited eröffnet Concept Store in Kalifornien Ladengeschäft wird über Bereich für eine Lounge u...

Probiodrug AG: Probiodrug AG to Publish its Full Year 2018 Results on March 28, 2019

DGAP-News: Probiodrug AG / Key word(s): Miscellaneous 21.03.2019 / 07:00 The issuer is solely responsible for the content of this announcement. Probiodrug AG to Publish its Full Year 2018 Results on March 28, 2019 HALLE (SAALE), Germany, 21 March 2019 - Probiodrug AG (Euronext Amsterdam: PBD), a clinical stage biopharmaceutical company developing novel therapeutic solutions to treat Al...

Wednesday 20th March 2019

p53 expression status is associated with cancer-specific survival in stage III and high-risk stage II colorectal cancer patients treated with oxaliplatin-based adjuvant chemotherapy

Global Variation of Nutritional Status in Children Undergoing Chronic Peritoneal Dialysis: A Longitudinal Study of the International Pediatric Peritoneal Dialysis Network

Eliminating superbugs on the International Space Station

An antimicrobial coating made of precious metals has reduced growth of bacteria on contamination-prone surfaces inside the International Space Station (ISS), where extreme conditions can foster antibiotic-resistant superbugs. When astronauts leave Earth, bacteria stay with them, remaining with them through spaceflight and on the unearthly conditions of the ISS. This creates a perfect storm of wea...

Immigrant women more likely to be overweight during pregnancy

(Oxford University Press USA) A new study in the Journal of Public Health finds that women in Norway from immigrant backgrounds are more likely to be overweight during pregnancy.

Brexit: A risky pitch of Parliament versus Public – BBC News

Brexit: A risky pitch of Parliament versus Public BBC NewsTheresa May says she is on the voter's side, but she needs to win over MPs to get her Brexit deal agreed.View full coverage on Google News

BlueCloud, the UBER-LIKE Model of HealthCare and Clinical Research, Unveils Its Global (DDIT™) Mechanisms

Globally tested and proven mechanisms provide current members with enhanced business and compliance connectivity tools. AUSTIN, Texas (PRWEB) March 20, 2019 BlueCloud by HealthCarePoint (HCP), today announced release of ground-breaking mechanisms specifically designed to help healthcare and clinical research stakeholders around the world improve patient care, stay in compliance with local and int...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks